Question 1

What is Artiva Biotherapeutics, Inc.'s accrued research and development expenses current?

Accepted Answer

Artiva Biotherapeutics, Inc. (ARTV) reported accrued research and development expenses current of $2.77M in Q2 2026.

Question 2

How has Artiva Biotherapeutics, Inc.'s accrued research and development expenses current changed year-over-year?

Accepted Answer

Artiva Biotherapeutics, Inc.'s accrued research and development expenses current increased by 209.6% year-over-year, from $894K to $2.77M.

Question 3

What is the long-term trend for Artiva Biotherapeutics, Inc.'s accrued research and development expenses current?

Accepted Answer

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s accrued research and development expenses current has grown at a -45.2% compound annual growth rate (CAGR), from $2.86M to $858K.

Question 4

What does accrued research and development expenses current mean?

Accepted Answer

Accrued Research And Development Expenses Current as reported by Artiva Biotherapeutics, Inc..

Line item	AS OF / JUNE 30,2026	AS OF / DECEMBER 31,2025
Accrued research and development expenses	$2,768	$858
Accrued payroll and other employee benefits	4,641	7,569
Accrued purchases	724	149
Other accrued expenses	1,763	1,024
Total accrued expenses	$9,896	$9,600

Accrued Research And Development Expenses Current at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Artiva Biotherapeutics, Inc.'s accrued research and development expenses current.

Artiva Biotherapeutics, Inc. ARTV Accrued Research And Development Expenses Current